STROBE Statement—Checklist of items that should be included in reports of cohort studies
STROBE 聲明-隊列研究報告中應包含的項目清單
Item No | Recommendation | Page No | |
Title and abstract | 1 | (a) Indicate the study’s design with a commonly used term in the title or the abstract | |
(b) Provide in the abstract an informative and balanced summary of what was done and what was found | |||
Introduction | |||
Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | |
Objectives | 3 | State specific objectives, including any prespecified hypotheses | |
Methods | |||
Study design | 4 | Present key elements of study design early in the paper | |
Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | |
Participants | 6 | (a) Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up | |
(b) For matched studies, give matching criteria and number of exposed and unexposed | |||
Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | |
Data sources/ measurement | 8* | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | |
Bias | 9 | Describe any efforts to address potential sources of bias | |
Study size | 10 | Explain how the study size was arrived at | |
Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | |
Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding | |
(b) Describe any methods used to examine subgroups and interactions | |||
(c) Explain how missing data were addressed | |||
(d) If applicable, explain how loss to follow-up was addressed | |||
(e) Describe any sensitivity analyses | |||
Results | |||
Participants | 13* | (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | |
(b) Give reasons for non-participation at each stage | |||
(c) Consider use of a flow diagram | |||
Descriptive data | 14* | (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders | |
(b) Indicate number of participants with missing data for each variable of interest | |||
(c) Summarise follow-up time (eg, average and total amount) | |||
Outcome data | 15* | Report numbers of outcome events or summary measures over time |